ChartRow logo
Share this page
TAK
$18.19-1.73%
as of close, Sep 30, 2026
☾ AH $18.19 -1.73%
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)Stock · Health Care
PeersMRNALLYUNHJNJMRKTMO

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) returns by year

As of market close, Sep 30, 2026

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) returns by year (2011–2026)#

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) annual returns by year
YearTotal return
2026YTD
+16.7%
2025
+20.5%
2024
-3.1%
2023
-8.5%
2022
+20.1%
2021
-21.6%
2020
-3.0%
2019
+22.5%
2018
-38.8%
2017
+41.3%
2016
-14.1%
2015
+24.4%
2014
-6.6%
2013
+7.3%
2012
+5.6%
2011
-5.0%
Annualized
+2.3%
2011–2026
Average year
+2.7%
15 full years
Best year
+41.3%
2017
Worst year
-38.8%
2018
Positive years
7/15
47% up

Total return by period#

Annual

Methodology#

Total returns, dividends reinvested, measured on TAK. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.

FAQ#

What is Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)'s average annual return?
Since 2011, Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) has returned about 2.3% a year (the compound annual growth rate) and an average calendar-year return of 2.7%.
What were Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)'s best and worst years?
Over 2011–2026, the best year was 2017 (+41.3%) and the worst was 2018 (-38.8%).
How often is Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) up in a year?
7 of the 15 full years since 2011 were positive — about 47% of the time.

More on Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)